Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable.

Παρόμοια τεκμήρια

• Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma.
  ανά: Hugosson, J, κ.ά.
  Έκδοση: (2004)
• Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening.
  ανά: Zackrisson, B, κ.ά.
  Έκδοση: (2003)
• Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden.
  ανά: Hugosson, J, κ.ά.
  Έκδοση: (2003)
• Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio.
  ανά: Aus, G, κ.ά.
  Έκδοση: (2004)
• The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable.
  ανά: Zackrisson, B, κ.ά.
  Έκδοση: (2004)